This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Fletcher S. Does the Christian conception of the sanctity of life call into question the practice of withdrawal of treatment as it has euthanasia? [Unpublished BA dissertation] Cheltenham: University of Gloucestershire; 2008.FletcherS.Does the Christian conception of the sanctity of life call into question the practice of withdrawal of treatment as it has euthanasia?[Unpublished BA dissertation]Cheltenham:University of Gloucestershire;2008.Search in Google Scholar
Lambert T, Benson G, Dolan G, et al. Practical aspects of extended half-life products for the treatment of haemophilia. Ther Adv Hematol 2018; 9(9): 295-308. doi: 10.1177/2040620718796429.LambertTBensonGDolanG.Practical aspects of extended half-life products for the treatment of haemophilia.Ther Adv Hematol2018;9(9):295-308. doi:10.1177/2040620718796429.Open DOISearch in Google Scholar
Fletcher S, Jenner K, Holland M, Khair K. The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me. Health Expect 2021; 25(1): 1-12. doi: 10.1111/hex.13404.FletcherSJennerKHollandMKhairK.The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me.Health Expect2021;25(1):1-12. doi:10.1111/hex.13404.Open DOISearch in Google Scholar
Makris M and Hermans C. A golden age for haemophilia treatment? Haemophilia 2018;24: 175-176. doi: 10.1111/hae.13411.MakrisMand HermansC.A golden age for haemophilia treatment?Haemophilia2018;24:175-176. doi:10.1111/hae.13411.Open DOISearch in Google Scholar
Fletcher S, Jenner K, Holland M, Chaplin S, Khair K. An exploration of why men with severe haemophilia might not want gene therapy: The Exigency study. Haemophilia 2021; 27: 11-15. doi: 10.1111/hae.14378.FletcherSJennerKHollandMChaplinSKhairK.An exploration of why men with severe haemophilia might not want gene therapy: The Exigency study.Haemophilia2021;27:11-15. doi:10.1111/hae.14378.Open DOISearch in Google Scholar
Fletcher S, Jenner K, Holland M, and Khair K. Expectation and loss when gene therapy for haemophilia is not an option: an Exigency sub-study. Haemophilia 2023; 29(3): 1-8. doi: 10.1111/hae.14774.FletcherSJennerKHollandM and KhairK.Expectation and loss when gene therapy for haemophilia is not an option: an Exigency sub-study.Haemophilia2023;29(3):1-8. doi:10.1111/hae.14774.Open DOISearch in Google Scholar
John Donne. Meditation XVII. In: Devotions upon Emergent Occasions Together with Death’s Duel. Michigan: Ann Arbor Publishing; 1959, 108-109.John Donne.Meditation XVII.In:Devotions upon Emergent Occasions Together with Death’s Duel.Michigan:Ann Arbor Publishing;1959,108-109.Search in Google Scholar
Fletcher S, Jenner K, Holland M, Khair K. Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet J Rare Dis 2024; 19: 59. doi: 10.1186/s13023-024-03068-2.FletcherSJennerKHollandMKhairK.Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study.Orphanet J Rare Dis2024;19:59. doi:10.1186/s13023-024-03068-2.Open DOISearch in Google Scholar
Fletcher S, Pembroke L, Holland M, Khair K. An exploration of the impact of gene therapy on the lives of people with haemophilia and their families: a protocol for the mixed-methods Exigency Study. BMJ Open 2022; 12: e060351. doi: 10.1136/bmjopen-2021-060351.FletcherSPembrokeLHollandMKhairK.An exploration of the impact of gene therapy on the lives of people with haemophilia and their families: a protocol for the mixed-methods Exigency Study.BMJ Open2022;12: e060351. doi:10.1136/bmjopen-2021-060351.Open DOISearch in Google Scholar
Fletcher S, Jenner K, Pembroke L, Holland M, Khair K. The experiences of people with haemophilia, and their families, of gene therapy in a clinical trial setting: Regaining Control, the Exigency Study. Orphanet J Rare Dis 2022; 17: 155. doi: 10.1186/s13023-022-02256-2.FletcherSJennerKPembrokeLHollandMKhairK.The experiences of people with haemophilia, and their families, of gene therapy in a clinical trial setting: Regaining Control, the Exigency Study.Orphanet J Rare Dis2022;17:155. doi:10.1186/s13023-022-02256-2.Open DOISearch in Google Scholar
Zimmer L. Qualitative meta-synthesis: A question of dialoguing with texts. J Adv Nurs 2006; 53: 311-8. doi: 10.1111/j.1365-2648.2006.03721.x.ZimmerL.Qualitative meta-synthesis: A question of dialoguing with texts.J Adv Nurs2006;53:311-8. doi:10.1111/j.1365-2648.2006.03721.x.Open DOISearch in Google Scholar
Finfgeld-Connett D. Generalizability and transferability of meta-synthesis research findings. J Adv Nurs 2010; 66: 246-54. doi: 10.1111/j.1365-2648.2009.05250.x.Finfgeld-ConnettD.Generalizability and transferability of meta-synthesis research findings.J Adv Nurs2010;66:24654. doi:10.1111/j.1365-2648.2009.05250.x.Open DOISearch in Google Scholar